Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK OFF JSpA)
Aim 1. To compare the likelihood of disease flare associated with fixed standard dosing, fixed longer dosing intervals, or stopping TNFi in children with spondyloarthritis who have inactive disease. Aim 2. To compare patients lived experiences in the three treatment arms (Standard dosing TNFi, Tapered dosing TNFi, and TNFi withdrawal).
Child to Adult
Childrens Hospital Colorado
Jennifer Cooper, MD
Protocol Number: 21-4033
More information available at ClinicalTrials.gov: NCT04891640
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers